In Vitro and In Vivo Characterization of Tebipenem, an Oral Carbapenem
Nicole S Cotroneo, Aileen Rubio, Ian A. Critchley, Chris M. Pillar, Michael J. Pucci
Spero Therapeutics (United States)
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
The continued evolution of bacterial resistance to the β-lactam class of antibiotics has necessitated countermeasures to ensure continued effectiveness in the treatment of infections caused by bacterial pathogens. One relatively successful approach has been the development of new β-lactam analogs with advantages over prior compounds in this class. The carbapenems are an example of such β-lactam analogs possessing improved stability against β-lactamase enzymes and, therefore, a wider spectrum of activity.
逐年被引趋势
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学Antibiotic Resistance in Bacteria
Antibiotics Pharmacokinetics and Efficacy · Bacterial Identification and Susceptibility Testing